Cargando…
P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers
P-glycoprotein or multidrug resistance protein (MDR1) is an adenosine triphosphate (ATP) binding cassette transporter (ABCB1) intensely investigated because it is an obstacle to successful pharmacotherapy of cancers. P-glycoprotein prevents cellular uptake of a large number of structurally and funct...
Autor principal: | Seelig, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649427/ https://www.ncbi.nlm.nih.gov/pubmed/33194688 http://dx.doi.org/10.3389/fonc.2020.576559 |
Ejemplares similares
-
Perplexing Role of P-Glycoprotein in Tumor Microenvironment
por: Robinson, Kianna, et al.
Publicado: (2020) -
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020) -
Pharmacotherapy Agents in Lymphedema Treatment: A Systematic Review
por: Forte, Antonio J, et al.
Publicado: (2019) -
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
por: Yoon, Sungpil, et al.
Publicado: (2021) -
The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)